about
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new...
Read More
1.42
-0.04
(-2.74%)
49,065
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Veraxa Biotech AG Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..